Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASCATAQ: Vascular Impact of Bevacizumab in Advanced Colorectal Cancer
NCT04813913Phase 4Completed
- Sponsor
- Rouen University Hospital
- Start
- May 2019
- Primary completion
- Jul 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in colorectal cancer (CRC), sponsored by Rouen University Hospital. Started May 2019; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04813913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04813913.